Year-over-year earnings per share growth for the last twelve months: OraSure Technologies (OSUR)

Brandmark of OraSure Technologies Inc (OSUR)

OraSure Technologies (OSUR) leads the rapid testing segment, leveraging unique saliva collection patents for both B2B and B2C sectors. High trust among medical professionals confirms its status as a global expert in infectious disease diagnostics. The quarterly EPS growth trajectory demonstrates the business's reaction to external shocks, where the metric value stands at -1.00. The company is currently updating its molecular testing line as it transitions to a maturity stage.

OraSure (OSUR) Earnings per share growth in annualized terms for the last twelve months: for the period 07/04/2022 - 11/14/2026

OSUR (orasure.com): analytical breakdowns and indicator data

- share price and expert price forecast:
Stock Price OraSure Corp|OSUR - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value OraSure Technologies, Inc.|OSUR - Company Buyout Price
- book capitalization data:
Net Assets per Single Share OraSure|OSUR - Total Stockholders' Equity|Market Value to Book Value Ratio orasure.com|OSUR - Aggregate Asset Value
- debt level and financial liquidity data:
Total Debt to Capital OraSure Technologies|OSUR - Long-Term Debt to Capital|Short-Term Debt to Equity OraSure Technologies, Inc.|OSUR - Company Total Debt Obligations|Debt to Book Value OraSure Corp|OSUR - Company Long-Term Debts|Company Short-Term Debt OraSure|Quick Ratio orasure.com
- earnings and market multiples details:
OSUR - Company Net Income|Future Profit OraSure Technologies|OSUR - Company Value to Net Income|Projected Price to Earnings OraSure Technologies Inc|OSUR - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple OraSure Technologies Inc|OSUR - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) OraSure|OSUR - Net earnings per share for the last 12 months|Quarterly EPS earnings growth orasure.com|OSUR - Earnings per share increase in current year|Net earnings per share growth forecast for next year OraSure Technologies
- sales volume and revenue indicators:
OSUR - Company Sales Volume|Company Projected Revenue orasure.com|OSUR - Price to Sales|Price-to-Projected Revenue Ratio OraSure
Analysis of all company metrics:OraSure Technologies, Inc., OSUR
Flagship merchandise of OraSure Technologies

This indicator measures the quarterly dynamics of earnings per share, determining the rate of capital recovery. The metric allows investors to filter out random market volatility from a sustainable financial trend. By analyzing the quarterly EPS growth rate, an investor assesses the actual efficiency of operational activities. For OraSure Technologies (OSUR), this figure confirms the successful transition to high-margin DNA collectors. The upward curve signals the monetization of new molecular devices and cost optimization.

Competitor analysis

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months illumina.com|Exact Sciences (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity (RVTY)|Year-over-year net earnings per share change for the last twelve months Bio-Rad Laboratories, Inc.|Year-over-year earnings per share growth for the last twelve months Anbio Biotechnology NNNN|Year-over-year earnings per share growth rate for the last twelve months SHC (Sterigenics)|quidel.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months OPKO Health|CDNA: Quarterly EPS earnings growth|Maravai LifeSciences Corp (MRVI) - Quarterly EPS earnings growth|FLGT (fulgentgenetics.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Standard BioTools Corp|Year-over-year net earnings per share growth for the last 12 months CTKB (Cytek Biosciences, Inc.)|XGN (Exagen) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MDxHealth MDXH|LUCD: Year-over-year earnings per share growth for the last 12 months|PRE - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IMDX (Insight Molecular Diagnostics Inc)|TRIB: Quarterly EPS earnings growth|prophaselabs.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months AIMD|Co-Diagnostics Corp (CODX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HSCS (Heart Test Laboratories Inc.)|Year-over-year net earnings per share change for the last twelve months Biomerica Inc|Year-over-year earnings per share growth for the last twelve months cardiodiagnosticsinc.com CDIO|ONCO: Year-over-year earnings per share growth for the last 12 months|VRAX - Year-over-year earnings per share growth for the last twelve months|BJDX (Bluejay Diagnostics Inc) - Year-over-year earnings per share growth for the last 12 months|AWH: Quarterly EPS earnings growth|Accelerate Diagnostics, Inc (AXDX) - Quarterly EPS earnings growth|CNTG (CENTOGENE, N.V.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo Biochem (ENZ)|Year-over-year net earnings per share growth for the last 12 months FRES (fresh2.co)|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe Inc ME|PMD: Year-over-year earnings per share growth for the last 12 months